Package 65162-630-03

{"route": ["ORAL"], "spl_id": "14950f16-445f-4f48-871f-31bc5328d099", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182141", "N0000185503", "N0000190113"], "upc": ["0365162630039"], "unii": ["304NUG5GF4"], "rxcui": ["311204"], "spl_set_id": ["2ab38a8a-3708-4b97-9f7f-8e554a15348d"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (65162-630-03)", "package_ndc": "65162-630-03", "marketing_start_date": "20160927"}], "brand_name": "Itraconazole", "product_id": "65162-630_14950f16-445f-4f48-871f-31bc5328d099", "dosage_form": "CAPSULE", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "65162-630", "generic_name": "Itraconazole", "labeler_name": "Amneal Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Itraconazole", "active_ingredients": [{"name": "ITRACONAZOLE", "strength": "100 mg/1"}], "application_number": "ANDA205080", "marketing_category": "ANDA", "marketing_start_date": "20160927", "listing_expiration_date": "20261231"}